China News Service, June 13th. According to a Reuters report on the 12th, the European Medicines Agency recently listed another rare blood disease, capillary leak syndrome (CLS), as a potential vaccine for AstraZeneca’s new crown vaccine. side effect.
Chinanews, May 10, according to the US Chinese website, after accusing AstraZeneca last month of failing to fulfill the initial contract for the new crown vaccine, the European Union did not renew the contract with the company that will expire in June.
China News Service, April 7th. Comprehensive foreign media reported that due to reports of rare cases of cerebral thrombosis after vaccination with AstraZeneca in many European countries, there has been controversy over the safety of the vaccine. The European Medicines Agency will release the latest review results of the vaccine on the 7th or 8th. At the same time, a World Health Organization official said on the 6th that there is no evidence for the WHO to change its position that the benefits of AstraZeneca vaccine still outweigh the risks.
China News Service, April 2nd. According to the “Central News Agency” report, the British medical regulatory agency said on the 1st that it had found 30 cases of rare thrombosis after vaccination with AstraZeneca, 25 more cases than previously reported, but the authorities still believe that The advantages of the AstraZeneca vaccine outweigh the disadvantages.
China News Service, March 31. According to a report from the Russian Satellite Network on the 31st, German Chancellor Angela Merkel stated that he would wait in line to receive the new crown vaccine and may choose the AstraZeneca vaccine.
Chinanews, March 29. According to the Russian Satellite Network, the European Medicines Agency will hold another meeting with experts on the 29th to continue investigating the occurrence of thromboembolic complications in patients receiving the AstraZeneca vaccine.
China News Service, March 25. According to the “Central News Agency” report, on the 24th local time, Finland and Iceland announced that elderly citizens will resume vaccination with AstraZeneca.